Literature DB >> 7772424

Prophylactic i.m. ephedrine in bupivacaine spinal anaesthesia.

J E Sternlo1, A Rettrup, R Sandin.   

Abstract

In a double-blind, placebo-controlled, randomized study, we have investigated the efficacy of i.m. ephedrine in 98 elderly patients undergoing hip arthroplasty under spinal anaesthesia with plain bupivacaine. Fifty patients received ephedrine 0.6 mg kg-1 body weight, deep in the paravertebral muscles immediately after injection of bupivacaine, and 48 received an equal volume of saline. Patients in both groups were given the same volumes of fluid before anaesthesia. Systolic arterial pressure during the first 60 min after anaesthesia remained significantly more stable in the ephedrine-treated group, and there was also a significantly smaller number of patients in this group who had decreases in pressure of more than 30% of pre-block levels, and fewer required rescue i.v. ephedrine. An increase in heart rate or systolic pressure of > or = 20% from baseline was found in two patients in the ephedrine group and in one patient in the placebo group. We conclude that ephedrine 0.6 mg kg-1 body weight administered in the paravertebral muscles immediately after plain bupivacaine spinal anaesthesia is a simple and effective means of reducing the incidence of hypotensive episodes in the elderly patient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772424     DOI: 10.1093/bja/74.5.517

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Efficacy of preanesthetic intramuscular administration of ephedrine for prevention of anesthesia-induced hypotension in cats and dogs.

Authors:  Christine Egger; Mary-Ann McCrackin; Erik Hofmeister; Gwenola Touzot-Jourde; Bart Rohrbach
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

2.  The efficacy of intramuscular ephedrine in preventing hemodynamic perturbations in patients with spinal anesthesia and dexmedetomidine sedation.

Authors:  Ji-Hyoung Park; Jae-Kwang Shim; Hyejin Hong; Hyun Kyo Lim
Journal:  Int J Med Sci       Date:  2020-08-25       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.